| 1 |
35560134 | Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer. | 2022 Jun 1 |
3 |
| 2 |
32789599 | Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial. | 2021 Feb |
1 |
| 3 |
33669095 | Development and Validation of a GMP-Compliant High-Pressure Liquid Chromatography Method for the Determination of the Chemical and Radiochemical Purity of [18F]PSMA-1007, a PET Tracer for the Imaging of Prostate Cancer. | 2021 Feb 25 |
1 |
| 4 |
34747721 | The performance of 18F-PSMA PET/CT in the detection of prostate cancer: a systematic review and meta-analysis. | 2021 Oct 29 |
1 |
| 5 |
31324713 | An 18F-Labeled PSMA Ligand for PET/CT of Prostate Cancer: First-in-Humans Observational Study and Clinical Experience with 18F-JK-PSMA-7 During the First Year of Application. | 2020 Feb |
1 |
| 6 |
30843003 | More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. | 2019 Jan-Apr |
2 |
| 7 |
31000583 | Simplified Methods for Quantification of 18F-DCFPyL Uptake in Patients with Prostate Cancer. | 2019 Dec |
1 |
| 8 |
31230088 | Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer. | 2019 Aug |
1 |
| 9 |
29503861 | Synthesis of an Al18F radiofluorinated GLU-UREA-LYS(AHX)-HBED-CC PSMA ligand in an automated synthesis platform. | 2018 |
1 |
| 10 |
29939893 | Prostate-specific membrane antigen for prostate cancer theranostics: from imaging to targeted therapy. | 2018 Sep |
1 |
| 11 |
30281701 | Clinical perspectives of PSMA PET/MRI for prostate cancer. | 2018 Sep 21 |
1 |
| 12 |
27847991 | Synthesis and pre-clinical evaluation of a new class of high-affinity 18F-labeled PSMA ligands for detection of prostate cancer by PET imaging. | 2017 Apr |
1 |
| 13 |
28950199 | Validation of a [Al18F]PSMA-11 preparation for clinical applications. | 2017 Dec |
1 |
| 14 |
28953234 | Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate Cancer. | 2017 Sep 27 |
3 |
| 15 |
25896814 | Initial Evaluation of [(18)F]DCFPyL for Prostate-Specific Membrane Antigen (PSMA)-Targeted PET Imaging of Prostate Cancer. | 2015 Aug |
1 |
| 16 |
26169882 | A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer. | 2015 Oct |
1 |
| 17 |
24615708 | Improving the biodistribution of PSMA-targeting tracers with a highly negatively charged linker. | 2014 May |
1 |